Respiratory Distress Syndrome, Newborn Clinical Trial
Official title:
Predictors for Nasal Intermittent Positive Pressure Ventilation Failure for Premature Infants With Respiratory Distress Syndrome
Non-invasive respiratory support methods have been widely used in premature babies with respiratory distress syndrome (RDS) which has changed the basic management of premature babies in the early period. According to the 2019 European Guidelines on RDS management, early nasal CPAP is recommended as first-line therapy in infants <30 weeks of age who are at risk of RDS who do not require mechanical ventilation (MV). However, some of the premature babies have faced non-invasive ventilation failure. Remarkably, infants who experience non-invasive ventilation failure are at increased risk of death, pneumothorax, intraventricular hemorrhage, and bronchopulmonary dysplasia (BPD), among other morbidities. In non-invasive ventilation failure, although demographic factors such as small gestational age, low birth weight, and male gender play a role, it has been suggested that surfactant deficiency may also play an important role. The most frequently reported risk factor in predicting non-invasive failure in studies is the fraction of inspiring oxygen during the first hours of life. In addition, positive end-expiratory airway pressure (PEEP) required for patient stabilization was found to be a potential predictor. However, there are still limited data to predict non-invasive ventilation failure. "Which newborns are at high risk for non-invasive ventilation failure?" and "When should the surfactant be applied?". The study is a single-center, prospective study to evaluate prognostic factors, and most importantly to define the FiO2 threshold, which is an indicator of possible non-invasive ventilation failure in infants supported with nasal intermittent positive pressure ventilation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01206946 -
Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants
|
Phase 2 | |
| Completed |
NCT00739115 -
The Use of Heliox Via Nasal CPAP to Prevent Early CPAP Failure in Premature Infants: A Feasibility Study
|
N/A | |
| Terminated |
NCT00486395 -
Will CPAP Reduce Length Of Respiratory Support In Premature Infants?
|
Phase 3 | |
| Completed |
NCT01242462 -
Feasibility of Mid-frequency Ventilation in Newborns With RDS: Randomized Crossover Pilot Trial
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT02050971 -
Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates
|
Phase 1 | |
| Completed |
NCT00486850 -
Synchronized Intermittent Mandatory Ventilation (SIMV) Versus Nasal Intermittent Positive Pressure Ventilation (NIPPV) In Preterm Infants With Respiratory Distress
|
Phase 4 | |
| Terminated |
NCT00005776 -
Inhaled Nitric Oxide Study for Respiratory Failure in Newborns
|
Phase 3 | |
| Completed |
NCT04500353 -
Routine Or Selective Application of a Face Mask for Preterm Infants at Birth: the ROSA Trial
|
N/A | |
| Completed |
NCT05796128 -
NIPPV vs.nCPAP During LISA Procedure
|
N/A | |
| Withdrawn |
NCT02835209 -
Positioning During SBT in NICU Infants
|
N/A | |
| Terminated |
NCT01467076 -
Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF)
|
Phase 2 | |
| Completed |
NCT00556738 -
Intrapulmonary Percussive Ventilation (IPV) Versus Nasal Continuous Positive Airway Pressure Ventilation (nCPAP) in Transient Respiratory Distress of the Newborn
|
N/A | |
| Completed |
NCT00828243 -
Genetic Regulation of Surfactant Deficiency
|
||
| Not yet recruiting |
NCT05594030 -
Thoracic Fluid Content by Electric Bioimpedance Versus Lung Ultrasound in Preterm Neonates With Respiratory Distress
|
||
| Completed |
NCT02332304 -
Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity.
|
Phase 3 | |
| Withdrawn |
NCT00598429 -
Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure
|
Phase 2 | |
| Completed |
NCT04137783 -
ABCA3 Gene and RDS in Late Preterm and Term Infants
|
||
| Completed |
NCT01941524 -
Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations
|
Phase 4 | |
| Completed |
NCT01102543 -
Observational Study on the Prophylactic Use of Curosurf in Neonatal Respiratory Distress Syndrome (RDS)
|
N/A | |
| Completed |
NCT00501982 -
Efficacy of Combining Prophylactic Curosurf With Early Nasal CPAP in Delivery Room: the Curpap Study
|
Phase 4 |